Low-burst polymers and methods to produce polymers
A PLG copolymer material, termed a PLG(p) copolymer material, adapted for use in a controlled release formulation for a bioactive material is provided, wherein the formulation exhibits a reduced “initial burst” effect when introduced into the tissue of a patient in need thereof. A method of preparation of the PLG copolymer material is also provided, as are methods of use.
1. A controlled release formulation comprising a flowable delivery system comprising a biocompatible, biodegradable, non-hydrolyzed PLG low-burst copolymer material for a controlled release formulation having a weight average molecular weight of about 10 kilodaltons to about 50 kilodaltons and a polydispersity index of about 1.4-2.0 and from which a removed copolymer fraction characterized by a weight average molecular weight of about 4 kDa to about 10 kDa and a polydispersity index of about 1.4 to 2.5 has been separated, an organic solvent, and leuprolide.
2. A method of treatment of a condition in a patient, comprising providing the patient with a therapeutically effective amount of the flowable delivery system of claim 1 comprising a medically indicated bioactive agent, wherein the condition is prostate cancer and the bioactive agent comprises leuprolide.